A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

NCT07498426 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Interventions

OTHER: NIO752
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals